Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

New England Journal of Medicine- United States

doi 10.1056/nejmoa0904492

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

Massachusetts Medical Society

Related search

Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report

Canadian Journal of General Internal Medicine
2014English

Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report

Canadian Journal of General Internal Medicine
1970English

Editorial: First Among Equals-Not for Either Infliximab or Adalimumab in Crohn's Disease-Yet

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease

The Lancet
Medicine
2017English

Efficacy of Adalimumab in Patients With Crohn's Disease and Failure to Infliximab Therapy: A Clinical Series

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2011English

Azathioprine Combination Therapy for Steroid-Refractory Hepatic Immune System-Related Adverse Events

European Journal of Dermatology
Dermatology
2017English

Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Successful Use of Maintenance Infliximab for Nephropathy in a Patient With Secondary Amyloidosis Complicating Crohn's Disease

Internal Medicine
Internal MedicineMedicine
2013English

Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy